Roger Jeffs - Net Worth and Insider Trading

Roger Jeffs Net Worth

The estimated net worth of Roger Jeffs is at least $51 Million dollars as of 2024-04-26. Roger Jeffs is the CEO of Liquidia Corp and owns about 2,415,247 shares of Liquidia Corp (LQDA) stock worth over $30 Million. Roger Jeffs is the Director of Axsome Therapeutics Inc and owns about 167,668 shares of Axsome Therapeutics Inc (AXSM) stock worth over $12 Million. Roger Jeffs is also the President & Co-CEO of United Therapeutics Corp and owns about 27,092 shares of United Therapeutics Corp (UTHR) stock worth over $6 Million. Besides these, Roger Jeffs also holds Dova Pharmaceuticals Inc (DOVA) , Sangamo Therapeutics Inc (SGMO) . Details can be seen in Roger Jeffs's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roger Jeffs has not made any transactions after 2024-04-12 and currently still holds the listed stock(s).

Transaction Summary of Roger Jeffs

To

Roger Jeffs Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roger Jeffs owns 7 companies in total, including Albireo Pharma Inc (ALBO) , Axsome Therapeutics Inc (AXSM) , and Dova Pharmaceuticals Inc (DOVA) among others .

Click here to see the complete history of Roger Jeffs’s form 4 insider trades.

Insider Ownership Summary of Roger Jeffs

Ticker Comapny Transaction Date Type of Owner
ALBO Albireo Pharma Inc 2017-09-27 director
AXSM Axsome Therapeutics Inc 2024-03-15 director
DOVA Dova Pharmaceuticals Inc 2019-11-12 director
SIOX Sio Gene Therapies Inc 2018-02-08 director
SGMO Sangamo Therapeutics Inc 2018-09-07 director
UTHR United Therapeutics Corp 2015-04-28 director & President and COO
LQDA Liquidia Corp 2024-03-18 director

Roger Jeffs Latest Holdings Summary

Roger Jeffs currently owns a total of 5 stocks. Among these stocks, Roger Jeffs owns 2,415,247 shares of Liquidia Corp (LQDA) as of April 12, 2024, with a value of $30 Million and a weighting of 59.92%. Roger Jeffs owns 167,668 shares of Axsome Therapeutics Inc (AXSM) as of March 15, 2024, with a value of $12 Million and a weighting of 23.81%. Roger Jeffs also owns 27,092 shares of United Therapeutics Corp (UTHR) as of April 28, 2015, with a value of $6 Million and a weighting of 12.54%. The other 2 stocks Dova Pharmaceuticals Inc (DOVA) , Sangamo Therapeutics Inc (SGMO) have a combined weighting of 3.73% among all his current holdings.

Latest Holdings of Roger Jeffs

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LQDA Liquidia Corp 2024-04-12 2,415,247 12.53 30,263,045
AXSM Axsome Therapeutics Inc 2024-03-15 167,668 71.71 12,023,472
UTHR United Therapeutics Corp 2015-04-28 27,092 233.85 6,335,464
DOVA Dova Pharmaceuticals Inc 2019-07-01 66,993 28.04 1,878,484
SGMO Sangamo Therapeutics Inc 2018-09-07 9,908 0.52 5,130

Holding Weightings of Roger Jeffs


Roger Jeffs Form 4 Trading Tracker

According to the SEC Form 4 filings, Roger Jeffs has made a total of 6 transactions in Liquidia Corp (LQDA) over the past 5 years, including 4 buys and 2 sells. The most-recent trade in Liquidia Corp is the sale of 8,360 shares on April 12, 2024, which brought Roger Jeffs around $121,889.

According to the SEC Form 4 filings, Roger Jeffs has made a total of 2 transactions in Axsome Therapeutics Inc (AXSM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Axsome Therapeutics Inc is the sale of 32,323 shares on March 15, 2024, which brought Roger Jeffs around $2 Million.

According to the SEC Form 4 filings, Roger Jeffs has made a total of 0 transactions in United Therapeutics Corp (UTHR) over the past 5 years. The most-recent trade in United Therapeutics Corp is the sale of 5,000 shares on April 28, 2015, which brought Roger Jeffs around $816,550.

More details on Roger Jeffs's insider transactions can be found in the Insider Trading History of Roger Jeffs table.

Insider Trading History of Roger Jeffs

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Roger Jeffs Trading Performance

GuruFocus tracks the stock performance after each of Roger Jeffs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roger Jeffs is 18.36%. GuruFocus also compares Roger Jeffs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roger Jeffs within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Roger Jeffs's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Roger Jeffs

Average Return

34.73%

Average return per transaction

Outperforming Transactions

83%

5 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.51 18.36 17.87 34.73 15.83 33
Relative Return to S&P 500(%) 14.01 15.59 14.65 28.7 11.27 21.17

Roger Jeffs Ownership Network

Ownership Network List of Roger Jeffs

No Data

Ownership Network Relation of Roger Jeffs


Roger Jeffs Owned Company Details

What does Albireo Pharma Inc do?

Who are the key executives at Albireo Pharma Inc?

Roger Jeffs is the director of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .

Albireo Pharma Inc (ALBO) Insider Trades Summary

Over the past 18 months, Roger Jeffs made no insider transaction in Albireo Pharma Inc (ALBO). Other recent insider transactions involving Albireo Pharma Inc (ALBO) include a net sale of 2,814 shares made by Pamela Stephenson , a net sale of 3,285 shares made by Jan Mattsson , and a net sale of 1,878 shares made by Harford Simon N.r. .

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,134 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,134 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Albireo Pharma Inc Insider Transactions

No Available Data

Roger Jeffs Mailing Address

Above is the net worth, insider trading, and ownership report for Roger Jeffs. Currently GuruFocus does not have mailing address information for Roger Jeffs.

Discussions on Roger Jeffs

No discussions yet.